Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46


Chaperone-Mediated Autophagy in the Liver: Good or Bad?

Dash S, Aydin Y, Moroz K.

Cells. 2019 Oct 24;8(11). pii: E1308. doi: 10.3390/cells8111308. Review.


Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.

Matossian MD, Burks HE, Elliott S, Hoang VT, Bowles AC, Sabol RA, Wahba B, Anbalagan M, Rowan B, Abazeed ME, Bunnell BA, Moroz K, Miele L, Rhodes LV, Jones SD, Martin EC, Collins-Burow BM, Burow ME.

BMC Cancer. 2019 Mar 7;19(1):205. doi: 10.1186/s12885-019-5401-2.


A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.

Matossian MD, Burks HE, Bowles AC, Elliott S, Hoang VT, Sabol RA, Pashos NC, O'Donnell B, Miller KS, Wahba BM, Bunnell BA, Moroz K, Zea AH, Jones SD, Ochoa AC, Al-Khami AA, Hossain F, Riker AI, Rhodes LV, Martin EC, Miele L, Burow ME, Collins-Burow BM.

Breast Cancer Res Treat. 2018 Jun;169(2):381-390. doi: 10.1007/s10549-018-4685-2. Epub 2018 Feb 1.


PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients.

Edwards DR, Moroz K, Zhang H, Mulholland D, Abdel-Mageed AB, Mondal D.

Int J Oncol. 2018 Feb;52(2):402-412. doi: 10.3892/ijo.2017.4208. Epub 2017 Nov 20.


Granulomatous Thyroiditis: A Case Report and Literature Review.

Trivedi DP, Bhagat R, Nakanishi Y, Wang A, Moroz K, Falk NK.

Ann Clin Lab Sci. 2017 Sep;47(5):620-624. Review.


Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture.

Aydin Y, Chedid M, Chava S, Danielle Williams D, Liu S, Hagedorn CH, Sumitran-Holgersson S, Reiss K, Moroz K, Lu H, Balart LA, Dash S.

Sci Rep. 2017 Aug 23;7(1):9223. doi: 10.1038/s41598-017-10087-6.


Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.

Chava S, Lee C, Aydin Y, Chandra PK, Dash A, Chedid M, Thung SN, Moroz K, Wu T, Nayak NC, Dash S.

Oncotarget. 2017 Jun 20;8(25):40019-40036. doi: 10.18632/oncotarget.16685.


Association of Malignancy Prevalence With Test Properties and Performance of the Gene Expression Classifier in Indeterminate Thyroid Nodules.

Al-Qurayshi Z, Deniwar A, Thethi T, Mallik T, Srivastav S, Murad F, Bhatia P, Moroz K, Sholl AB, Kandil E.

JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):403-408. doi: 10.1001/jamaoto.2016.3526.


Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer.

Abd Elmageed ZY, Sholl AB, Tsumagari K, Al-Qurayshi Z, Basolo F, Moroz K, Boulares AH, Friedlander P, Miccoli P, Kandil E.

Surgery. 2017 Apr;161(4):1122-1128. doi: 10.1016/j.surg.2016.06.081. Epub 2016 Dec 2.


Identification of microRNA signature and potential pathway targets in prostate cancer.

Moustafa AA, Ziada M, Elshaikh A, Datta A, Kim H, Moroz K, Srivastav S, Thomas R, Silberstein JL, Moparty K, Salem FE, El-Habit OH, Abdel-Mageed AB.

Exp Biol Med (Maywood). 2017 Mar;242(5):536-546. doi: 10.1177/1535370216681554. Epub 2016 Dec 8.


Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations.

Seijo E, Lima D, Iriabho E, Almeida J, Monico J, Echeverri M, Gutierrez S, Flores I, Lee JH, Fisher K, Grizzle WE, Sica GL, Butler C, Hicks C, Meade CD, Sodeke SO, Moroz K, Coppola D, Munoz-Antonia T.

Cancer Control. 2016 Oct;23(4):383-389.


Optimal timing for a repeat fine-needle aspiration biopsy of thyroid nodule following an initial nondiagnostic fine-needle aspiration.

Deniwar A, Hammad AY, Ali DB, Alsaleh N, Lahlouh M, Sholl AB, Moroz K, Aslam R, Thethi T, Kandil E.

Am J Surg. 2017 Feb;213(2):433-437. doi: 10.1016/j.amjsurg.2016.04.010. Epub 2016 Jun 14.


Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.

Zhang J, Baddoo M, Han C, Strong MJ, Cvitanovic J, Moroz K, Dash S, Flemington EK, Wu T.

Oncotarget. 2016 Aug 2;7(31):49232-49245. doi: 10.18632/oncotarget.10249.


Lack of mutation-histopathology correlation in a patient with Proteus syndrome.

Doucet ME, Bloomhardt HM, Moroz K, Lindhurst MJ, Biesecker LG.

Am J Med Genet A. 2016 Jun;170(6):1422-1432. doi: 10.1002/ajmg.a.37612. Epub 2016 Apr 26.


Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.

Yang Y, Jia D, Kim H, Abd Elmageed ZY, Datta A, Davis R, Srivastav S, Moroz K, Crawford BE, Moparty K, Thomas R, Hudson RS, Ambs S, Abdel-Mageed AB.

Clin Cancer Res. 2016 Apr 1;22(7):1744-56. doi: 10.1158/1078-0432.CCR-15-1606. Epub 2015 Nov 9.


Examining the Bethesda criteria risk stratification of thyroid nodules.

Deniwar A, Hambleton C, Thethi T, Moroz K, Kandil E.

Pathol Res Pract. 2015 May;211(5):345-8. doi: 10.1016/j.prp.2015.02.005. Epub 2015 Feb 27.


The impact of thyroid nodule size on the risk of malignancy in follicular neoplasms.

Ibrahim Y, Mohamed SE, Deniwar A, Al-Qurayshi ZH, Khan AN, Moroz K, Friedlander P, Kandil E.

Anticancer Res. 2015 Mar;35(3):1635-9.


EWS-WT1 oncoprotein activates neuronal reprogramming factor ASCL1 and promotes neural differentiation.

Kang HJ, Park JH, Chen W, Kang SI, Moroz K, Ladanyi M, Lee SB.

Cancer Res. 2014 Aug 15;74(16):4526-35. doi: 10.1158/0008-5472.CAN-13-3663. Epub 2014 Jun 16.


In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.

McCarthy M, Auda G, Agrawal S, Taylor A, Backstrom Z, Mondal D, Moroz K, Dash S.

Exp Mol Pathol. 2014 Aug;97(1):6-15. doi: 10.1016/j.yexmp.2014.04.013. Epub 2014 Apr 26.


Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes.

Abd Elmageed ZY, Yang Y, Thomas R, Ranjan M, Mondal D, Moroz K, Fang Z, Rezk BM, Moparty K, Sikka SC, Sartor O, Abdel-Mageed AB.

Stem Cells. 2014 Apr;32(4):983-97. doi: 10.1002/stem.1619.

Supplemental Content

Loading ...
Support Center